Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Assay of Inhibition of Escherichia coli RNA Polymerase from US Patent US20250115594: "ANTIBACTERIAL AGENTS: SOLUBLE SALTS AND AQUEOUS FORMULATIONS OF PYRONINS"
Assay data:7 Active, 7 Activity ≤ 1 μM, 7 Tested
Summary Compounds, Active Compounds, activity ≤ 1 μM Related BioAssays by Depositor Related BioAssays by Target
Assay of Inhibition of Staphylococcus aureus RNA Polymerase from US Patent US20250115594: "ANTIBACTERIAL AGENTS: SOLUBLE SALTS AND AQUEOUS FORMULATIONS OF PYRONINS"
Assay data:6 Active, 1 Activity ≤ 1 nM, 6 Activity ≤ 1 μM, 6 Tested
Summary Compounds, Active Compounds, activity ≤ 1 μM Related BioAssays by Depositor
Assay of Inhibition of Mycobacterium tuberculosis RNA Polymerase from US Patent US20250115594: "ANTIBACTERIAL AGENTS: SOLUBLE SALTS AND AQUEOUS FORMULATIONS OF PYRONINS"
Assay data:4 Active, 4 Activity ≤ 1 μM, 6 Tested
Measurement of Half Maximal Inhibitory Concentration (IC50) from US Patent US12263156: "Use of small molecule inhibitors of the BfrB:Bfd interaction in biofilms"
Assay data:10 Active, 3 Activity ≤ 1 μM, 14 Tested
Summary Compounds, Active Compounds, activity ≤ 1 μM
Enzyme Inhibition Assay from US Patent US12258342: "Class of DNA gyrase and/or topoisomerase IV inhibitors with activity against gram-positive and gram-negative bacteria"
Assay data:44 Active, 42 Activity ≤ 1 μM, 45 Tested
Summary Compounds, Active Compounds, activity ≤ 1 μM Related BioAssays by Target
MraY Assay from US Patent US20250092081: "USE OF GLYCOSYLTRASNFERASE INHIBITORS FOR TREATING CANCER"
Assay data:5 Active, 3 Activity ≤ 1 μM, 6 Tested
WecA Assay from US Patent US20250092081: "USE OF GLYCOSYLTRASNFERASE INHIBITORS FOR TREATING CANCER"
Assay data:4 Active, 3 Activity ≤ 1 μM, 6 Tested
Fluorometric Assay from US Patent US12247013: "Indane derivatives for use in the treatment of bacterial infection"
Assay data:49 Active, 35 Activity ≤ 1 μM, 49 Tested
Enzyme Inhibition Assay from US Patent US12247004: "2-amino-N-(amino-oxo-aryl-lambda6-sulfanylidene)acetamide compounds and their therapeutic use"
Assay data:187 Active, 99 Activity ≤ 1 μM, 213 Tested
First Todd Group Plate of Idler compounds
Assay data:20 Active, 96 Tested
Summary Compounds, Active
Bioactivity Assay (pH=7.5) from US Patent US20250051321: "TRICYCLIC DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF"
Assay data:38 Active, 34 Activity ≤ 1 μM, 38 Tested
Bioactivity Assay (pH=8.5) from US Patent US20250051321: "TRICYCLIC DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF"
Assay data:118 Active, 118 Activity ≤ 1 μM, 118 Tested
Inhibitory Concentration (IC50) to UDP-2,3-diacylglucosamine hydrolase (LpxH) from US Patent US20250011300: "PIPERAZINYLSULFONYLARYL COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS"
Assay data:98 Active, 98 Activity ≤ 1 μM, 98 Tested
Fluorescence Polarization (FP) Competition Binding Assay from US Patent US12173018: "Penicillin-binding protein inhibitors"
Assay data:207 Tested
Summary Related BioAssays by Target
Enzymatic Assay from US Patent US20240417387: "SULFONYLPIPERAZINYL COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS"
Assay data:63 Active, 63 Activity ≤ 1 μM, 63 Tested
Inhibition of E. faecalis Decarboxylation Activity In Vitro from US Patent US12162902: "Decarboxylase inhibitors for treating Parkinson's disease"
Assay data:1 Active, 11 Tested
Summary Compounds, Active Related BioAssays by Depositor
Inhibition of Tyrosine Decarboxylase In Vitro from US Patent US12162902: "Decarboxylase inhibitors for treating Parkinson's disease"
Assay data:4 Active, 14 Tested
LpxC Enzymatic Activity Assay from US Patent US20240382465: "AROMATIC ACETYLENE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF"
Assay data:93 Active, 93 Activity ≤ 1 μM, 93 Tested
Enzyme Activity: Determination of IC50 from US Patent US10544130: "Metallo-beta-lactamase inhibitors"
Assay data:489 Active, 328 Activity ≤ 1 nM, 489 Activity ≤ 1 μM, 489 Tested
Ligand Binding Assay from Article 10.1128/aac.00311-07: "Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography."
Assay data:7 Active, 13 Tested
Summary Compounds, Active PubMed Citation
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
AltStyle によって変換されたページ (->オリジナル) / アドレス: モード: デフォルト 音声ブラウザ ルビ付き 配色反転 文字拡大 モバイル